Abstract

Fludarabine Phosphate 25-mg/mL Injection

Author(s): Allen Loyd V Jr

Issue: Mar/Apr 2014 - Volume 18, Number 2

Page(s): 143

Download in electronic PDF format for $75
  • Fludarabine Phosphate 25-mg/mL Injection Page 1

Abstract

A formulation for preparing Fludarabine Phosphate 25-mg/mL Injection. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • B- cell chronic lymphocytic leukemia
  • formulation
  • fludarabine phosphate
  • purine analog
  • compounded sterile preparations
  • intravenous administration

Related Categories

  • CANCER AND AIDS
  • FORMULATIONS
  • STERILE PREPARATIONS

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Mar/Apr 2014
Pg. 143
Fludarabine Phosphate 25-mg/mL Injection
Author(s): Allen Loyd V Jr
Jul/Aug 2001
Pg. 320-322
A New High-Performance Liquid Chromatographic Method for Fludarabine and Fludarabine Phosphate Compounded in Liposomes
Author(s): Abang Anthony M, Abbas S Ali, Pham Trinh, Lambros Maria Polikandritou
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Nov/Dec 2004
Pg. 462-465
Basics of Compounding for Cough
Author(s): Allen Loyd V Jr
Nov/Dec 2015
Pg. 508
Dexamethasone Sodium Phosphate Ophthalmic Solution: Equivalent to 0.1% Dexamethasone Phosphate
Author(s): Allen Loyd V Jr
Mar/Apr 2021
Pg. 131-139
Intravenous Admixture Preparation Considerations, Part 9-A: Error Prevention in Intravenous Admixture Preparation
Author(s): Allen Loyd V Jr
Jul/Aug 2023
Pg. 305-313
Sterile Basics of Compounding: Intravenous Admixture Compounding, Part 3: Preparation Procedures
Author(s): Allen Loyd V Jr
Sep/Oct 2018
Pg. 387-398
Compounding Enclosures: Ensuring Safety During the Preparation of Sterile and Nonsterile Formulations
Author(s): Ashe Krystina, Baskett Dustin
May/Jun 2020
Pg. 215-220
Sterile Basics: Intravenous Admixture Preparation Considerations, Part 4: Particulates
Author(s): Allen Loyd V Jr
Jul/Aug 2021
Pg. 311-317
Basics of Sterile Compounding: Intravenous Admixture Preparation Considerations, Part 10: Packaging and Container-closure Issues
Author(s): Allen Loyd V Jr
Jul/Aug 2020
Pg. 315
Hydrocortisone Hemisuccinate 2 mg/mL or Hydrocortisone Sodium Phosphate 2 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
May/Jun 2021
Pg. 222-229
Intravenous Admixture Preparation Considerations, Part 9-B: Error Prevention in Intravenous Admixture Preparation
Author(s): Allen Loyd V Jr
Nov/Dec 2021
Pg. 491-496
Basics of Sterile Compounding: Intravenous Admixture Preparation, Part 12: United States Pharmacopeia Chapters Referenced in the Current United States Pharmacopeia Chapter <797> Pharmaceutical Compounding -- Sterile Preparations
Author(s): Allen Loyd V Jr
May/Jun 2019
Pg. 221-228
Basics of Sterile Compounding: Vehicles Used in Sterile Compounding
Author(s): Allen Loyd V Jr
Sep/Oct 2023
Pg. 397-409
Basics of Sterile Compounding: Sterile Basics of Compounding Intravenous Admixtures, Part 4: Physicochemical Considerations
Author(s): Allen Loyd V Jr
Jan/Feb 2007
Pg. 78
Prednisolone Sodium Phosphate 10-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Mar/Apr 2023
Pg. 123-139
Sterile Basics: Intravenous Admixture Compounding, Part 1: Introduction and Overview of the General Guidelines for an Intravenous Admixture Compounding Program, and Compounding Personnel Considerations
Author(s): Allen Loyd V Jr
Jul/Aug 2020
Pg. 305-309
Sterile Basics: Intravenous Admixture Preparation Considerations, Part 5: pH Considerations
Author(s): Allen Loyd V Jr
Mar/Apr 2022
Pg. 141
Codeine Phosphate 3 mg/mL in Ora-Sweet
Author(s): Allen Loyd V Jr
May/Jun 2019
Pg. 231
Chloroquine Phosphate 15 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr